Fast neutron radiotherapy for primary mucosal melanomas of the head and neck

Head and Neck

Volumn 36, Issue 8, 2014, Pages 1162-1167

  Liao, Jay J ^a   Parvathaneni, Upendra ^a   Laramore, George E ^a   Thompson, John A ^b   Bhatia, Shailender ^b   Futran, Neal D ^b   Bhrany, Amit D ^b   Hawes, Stephen E ^b   Ladra, Matthew ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

fast neutrons; head and neck neoplasms; mucosal melanoma; radiotherapy; sinonasal

Indexed keywords

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER CONTROL; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISTANT METASTASIS; FAST NEUTRON THERAPY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LINEAR ENERGY TRANSFER; LIP; MALE; MEDICAL RECORD REVIEW; MINIMAL RESIDUAL DISEASE; NOSE; OVERALL SURVIVAL; PALATE; PRIMARY HEAD AND NECK MUCOSAL MELANOMA; PRIORITY JOURNAL; SKIN MANIFESTATION; XEROSTOMIA; ADVERSE EFFECTS; FAST NEUTRON RADIATION; HEAD AND NECK NEOPLASMS; MELANOMA; MIDDLE AGED; MUCOSA; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL; THERAPEUTIC USE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FAST NEUTRONS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUCOUS MEMBRANE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84904259115     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23428     Document Type: Article

References (33)

1. Lücke A,. Die Lehre von den Geschwülsten in anatomischer und klinischer Beziehung. In: Handbuch der allgemeinen und speciellen Chirurgie, 2. Erlangen: F. Enke; 1869.
2. Chang AE, Karnell LH, Menck HR,. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1664-1678.
3. Yanagi T, Mizoe JE, Hasegawa A, et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2009; 74: 15-20.
4. Moreno MA, Roberts DB, Kupferman ME, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer 2010; 116: 2215-2223.
5. Mendenhall WM, Amdur RJ, Hinerman RW, Werning JW, Villaret DB, Mendenhall NP,. Head and neck mucosal melanoma. Am J Clin Oncol 2005; 28: 626-630.
6. Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002; 24: 247-257.
7. Gavriel H, McArthur G, Sizeland A, Henderson M,. Review: mucosal melanoma of the head and neck. Melanoma Res 2011; 21: 257-266.
8. Stern SJ, Guillamondegui OM,. Mucosal melanoma of the head and neck. Head Neck 1991; 13: 22-27.
9. Lund VJ, Howard DJ, Harding L, Wei WI,. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999; 109 (2 Pt 1): 208-211.
10. Temam S, Mamelle G, Marandas P, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005; 103: 313-319.
11. Owens JM, Roberts DB, Myers JN,. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003; 129: 864-868.
12. Gilligan D, Slevin NJ,. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol 1991; 64: 1147-1150.
13. Harwood AR, Cummings BJ,. Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys 1982; 8: 1121-1126.
14. Shibuya H, Takeda M, Matsumoto S, Hoshina M, Suzuki S, Takagi M,. The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys 1993; 25: 35-39.
15. Wada H, Nemoto K, Ogawa Y, et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys 2004; 59: 495-500.
16. Trotti A, Peters LJ,. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol 1993; 9: 246-250.
17. Tsunemoto H, Morita S, Satoh S, Iino Y, Yoo Y,. Present status of fast neutron therapy in Asian countries. Strahlenther Onkol 1989; 165: 330-336.
18. Cohen L, Hendrickson FR, Kurup PD, et al. Clinical evaluation of neutron beam therapy. Current results and prospects, 1983. Cancer 1985; 55: 10-17.
19. Wambersie A, Richard F, Breteau N,. Development of fast neutron therapy worldwide. Radiobiological, clinical and technical aspects. Acta Oncol 1994; 33: 261-274.
20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p 648.
21. Marti F, editor. American Physical Society. Tenth International Conference on Cyclotrons and their Applications: April 30-May 3, 1984, East Lansing, Michigan, U.S.A. Institute of Electrical and Electronics Engineers (New York, NY. Piscataway, NJ). Copies may be obtained from IEEE Service Center; 1984. p 755.
22. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
23. Bachar G, Loh KS, O'Sullivan B, et al. Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck 2008; 30: 1325-1331.
24. Hall EJ, Giaccia AJ,. Radiobiology for the radiologist. 7th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams &38; Wilkins; 2011.
25. Blake PR, Catterall M, Errington RD,. Treatment of malignant melanoma by fast neutrons. Br J Surg 1985; 72: 517-519.
26. Zink S, Antoine J, Mahoney FJ,. Fast neutron therapy clinical trials in the United States. Am J Clin Oncol 1989; 12: 277-282.
27. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE,. Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 2003; 129: 944-948.
28. Shuman AG, Light E, Olsen SH, et al. Mucosal melanoma of the head and neck: predictors of prognosis. Arch Otolaryngol Head Neck Surg 2011; 137: 331-337.
29. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-723.
30. Beadling C, Jacobson-Dunlop E, Hodi FS, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008; 14: 6821-6828.
31. Guo J, Si L, Kong Y, et al. Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol 2011; 29: 2904-2909.
32. Chapman PB, Hauschild A, Robert C, et a. Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with V600EBRAF-mutated melanoma. J Clin Oncol 2011; 29 (suppl):abstr LBA4.
33. Turri-Zanoni M, Medicina D, Lombardi D, et al. Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck 2013; 35: 1066-1077.